Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Chhabra S, Szabo A, Clurman A, McShane K, Waters N, Eastwood D, Samanas L, Fei T, Armijo G, Abedin S, Longo W, Hari P, Hamadani M, Shah NN, Runaas L, Jerkins JH, Van den Brink M, Peled JU, Drobyski WR.
Chhabra S, et al. Among authors: eastwood d.
Haematologica. 2023 Jan 1;108(1):250-256. doi: 10.3324/haematol.2022.281309.
Haematologica. 2023.
PMID: 36106394
Free PMC article.
No abstract available.